{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:24:19Z","timestamp":1759602259731},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s12032-013-0606-8","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T12:37:46Z","timestamp":1369053466000},"source":"Crossref","is-referenced-by-count":13,"title":["Smad3 is the key to transforming growth factor-\u03b21-induced osteoclast differentiation in giant cell tumor of bone"],"prefix":"10.1007","volume":"30","author":[{"given":"Zhiyuan","family":"Lou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianbo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunshan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"issue":"3","key":"606_CR1","first-page":"207","volume":"12","author":"M Karpik","year":"2010","unstructured":"Karpik M. Giant cell tumor (tumor gigantocellularis, osteoclastoma)\u2014epidemiology, diagnosis, treatment. Ortop Traumatol Rehabil. 2010;12(3):207\u201315.","journal-title":"Ortop Traumatol Rehabil"},{"issue":"2","key":"606_CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4055\/cios.2012.4.2.107","volume":"4","author":"Y Kim","year":"2012","unstructured":"Kim Y, Nizami S, Goto H, Lee FY. Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor. Clin Orthop Surg. 2012;4(2):107\u201316. doi: 10.4055\/cios.2012.4.2.107 .","journal-title":"Clin Orthop Surg"},{"issue":"4","key":"606_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/CCO.0b013e32832c951d","volume":"21","author":"DM Thomas","year":"2009","unstructured":"Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol. 2009;21(4):338\u201344. doi: 10.1097\/CCO.0b013e32832c951d .","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"606_CR4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s004320100234","volume":"127","author":"M Wulling","year":"2001","unstructured":"Wulling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E. The nature of giant cell tumor of bone. J Cancer Res Clin Oncol. 2001;127(8):467\u201374.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"606_CR5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/S0046-8177(03)00413-1","volume":"34","author":"M Wulling","year":"2003","unstructured":"Wulling M, Delling G, Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. Human Pathol. 2003;34(10):983\u201393. doi: 10.1053\/s0046-8177(03)00413-1 .","journal-title":"Human Pathol"},{"issue":"2","key":"606_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0019-5413.32041","volume":"41","author":"A Gupta","year":"2007","unstructured":"Gupta A, Nath R, Mishra M. Giant cell tumor of bone: multimodal approach. Indian J Orthop. 2007;41(2):115\u201320. doi: 10.4103\/0019-5413.32041 .","journal-title":"Indian J Orthop"},{"issue":"2","key":"606_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L. Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473(2):139\u201346. doi: 10.1016\/j.abb.2008.03.018 .","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"606_CR8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5435\/JAAOS-21-02-118","volume":"21","author":"KA Raskin","year":"2013","unstructured":"Raskin KA, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJ. Giant cell tumor of bone. J Am Acad Orthop Surg. 2013;21(2):118\u201326. doi: 10.5435\/jaaos-21-02-118 .","journal-title":"J Am Acad Orthop Surg"},{"issue":"2","key":"606_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"D Lacey","year":"1998","unstructured":"Lacey D, Timms E, Tan H-L, Kelley M, Dunstan C, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93(2):165\u201376.","journal-title":"Cell"},{"key":"606_CR10","unstructured":"Roudier M, Kellar-Graney K, Huang L (eds) Increased expression of RANKL in giant cell tumours of the bone correlates with recurrence. In: 13th annual connective tissue oncology society meeting. 2007."},{"issue":"1","key":"606_CR11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-3701-3-4","volume":"3","author":"S Kasagi","year":"2013","unstructured":"Kasagi S, Chen W. TGF-beta1 on osteoimmunology and the bone component cells. Cell biosci. 2013;3(1):4. doi: 10.1186\/2045-3701-3-4 .","journal-title":"Cell biosci"},{"issue":"27","key":"606_CR12","doi-asserted-by":"crossref","first-page":"24571","DOI":"10.1074\/jbc.M202561200","volume":"277","author":"S-M K\u00e4k\u00f6nen","year":"2002","unstructured":"K\u00e4k\u00f6nen S-M, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, et al. Transforming growth factor-\u03b2 stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem. 2002;277(27):24571\u20138.","journal-title":"J Biol Chem"},{"issue":"5","key":"606_CR13","first-page":"1095","volume":"145","author":"MH Zheng","year":"1994","unstructured":"Zheng MH, Fan Y, Wysocki SJ, Lau A, Robertson T, Beilharz M, et al. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol. 1994;145(5):1095.","journal-title":"Am J Pathol"},{"issue":"1","key":"606_CR14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","volume":"69A","author":"M Campanacci","year":"1987","unstructured":"Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Jt Surg Am. 1987;69A(1):106\u201314.","journal-title":"J Bone Jt Surg Am"},{"key":"606_CR15","unstructured":"Chuan-han F, Yu-hui C, Jia-jing Z, Hua-long J. In vitro tissue culture study on giant cell tumor of bone. J Peking Univ Health Sci. 1980;1:000."},{"issue":"6","key":"606_CR16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/CEJ.0b013e32833d942f","volume":"19","author":"X Tang","year":"2010","unstructured":"Tang X, Lu X, Guo W, Ren T, Zhao H, Zhao F, et al. Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line. Eur J Cancer Prev. 2010;19(6):466\u201371.","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"606_CR17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<284::AID-PATH94>3.0.CO;2-Z","volume":"185","author":"A Franchi","year":"1998","unstructured":"Franchi A, Arganini L, Baroni G, Calzolari A, Capanna R, Campanacci D, et al. Expression of transforming growth factor \u03b2 isoforms in osteosarcoma variants: association of tgf\u03b21 with high-grade osteosarcomas. J Pathol. 1998;185(3):284\u20139.","journal-title":"J Pathol"},{"issue":"24","key":"606_CR18","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/jnci\/91.24.2096","volume":"91","author":"H Gobbi","year":"1999","unstructured":"Gobbi H, Dupont WD, Simpson JF, Plummer WD, Schuyler PA, Olson SJ, et al. Transforming growth factor-\u03b2 and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst. 1999;91(24):2096\u2013101.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"606_CR19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10555-006-9021-3","volume":"25","author":"WC Dougall","year":"2006","unstructured":"Dougall WC, Chaisson M. The RANK\/RANKL\/OPG triad in cancer-induced bone diseases. Cancer Metastasis Rev. 2006;25(4):541\u20139. doi: 10.1007\/s10555-006-9021-3 .","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"606_CR20","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/en.142.12.5050","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S. Minireview: the opg\/rankl\/rank system. Endocrinology. 2001;142(12):5050\u20135.","journal-title":"Endocrinology"},{"issue":"1","key":"606_CR21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","volume":"208","author":"S Tanaka","year":"2005","unstructured":"Tanaka S, Nakamura K, Takahasi N, Suda T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL\u2013RANK signaling system. Immunol Rev. 2005;208(1):30\u201349.","journal-title":"Immunol Rev"},{"issue":"5","key":"606_CR22","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0002-9440(10)63560-2","volume":"163","author":"E Grimaud","year":"2003","unstructured":"Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N, et al. Receptor activator of nuclear factor kappa B ligand (RANKL)\/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol. 2003;163(5):2021\u201331.","journal-title":"Am J Pathol"},{"issue":"3","key":"606_CR23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9440(10)64942-5","volume":"156","author":"L Huang","year":"2000","unstructured":"Huang L, Xu JK, Wood DJ, Zheng MH. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-{kappa} B in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol. 2000;156(3):761\u20137.","journal-title":"Am J Pathol"},{"key":"606_CR24","doi-asserted-by":"crossref","unstructured":"Singh S, Mak I, Cowan RW, Turcotte R, Singh G, Ghert M. The role of TWIST as a regulator in giant cell tumor of bone. J Cell Biochem. 2011. doi: 10.1002\/jcb.23149 .","DOI":"10.1002\/jcb.23149"},{"issue":"4","key":"606_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/modpathol.2008.29","volume":"21","author":"BC Dickson","year":"2008","unstructured":"Dickson BC, Li SQ, Wunder JS, Ferguson PC, Eslami B, Werier JA, et al. Giant cell tumor of bone express p63. Mod Pathol. 2008;21(4):369\u201375. doi: 10.1038\/modpathol.2008.29 .","journal-title":"Mod Pathol"},{"issue":"7","key":"606_CR26","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki SI, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA. 1998;95(7):3597\u2013602.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"606_CR27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jcb.22538","volume":"110","author":"S Jurado","year":"2010","unstructured":"Jurado S, Garcia-Giralt N, Diez-Perez A, Esbrit P, Yoskovitz G, Agueda L, et al. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. J Cell Biochem. 2010;110(2):304\u201310. doi: 10.1002\/jcb.22538 .","journal-title":"J Cell Biochem"},{"issue":"6","key":"606_CR28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002640050290","volume":"22","author":"E Solheim","year":"1998","unstructured":"Solheim E. Growth factors in bone. Int Orthop. 1998;22(6):410\u20136.","journal-title":"Int Orthop"},{"issue":"1","key":"606_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-3-4","volume":"3","author":"S Kasagi","year":"2013","unstructured":"Kasagi S, Chen W. TGF-beta1 on osteoimmunology and the bone component cells. Cell Biosci. 2013;3(1):1\u20137.","journal-title":"Cell Biosci"},{"issue":"11","key":"606_CR30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel PM, Massagu\u00e9 J. Cytostatic and apoptotic actions of TGF-\u03b2 in homeostasis and cancer. Nat Rev Cancer. 2003;3(11):807\u201320.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"606_CR31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00240-003-0360-z","volume":"32","author":"D Mitropoulos","year":"2004","unstructured":"Mitropoulos D, Kiroudi A, Christelli E, Serafetinidis E, Zervas A, Anastasiou I, et al. Expression of transforming growth factor \u03b2 in renal cell carcinoma and matched non-involved renal tissue. Urol Res. 2004;32(5):317\u201322.","journal-title":"Urol Res"},{"issue":"2","key":"606_CR32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/mol.105.017483","volume":"69","author":"M Jinnin","year":"2006","unstructured":"Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006;69(2):597\u2013607. doi: 10.1124\/mol.105.017483 .","journal-title":"Mol Pharmacol"},{"issue":"7","key":"606_CR33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jbmr.357","volume":"26","author":"T Yasui","year":"2011","unstructured":"Yasui T, Kadono Y, Nakamura M, Oshima Y, Matsumoto T, Masuda H, et al. Regulation of RANKL-induced osteoclastogenesis by TGF-\u03b2 through molecular interaction between Smad3 and Traf6. J Bone Miner Res. 2011;26(7):1447\u201356.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"606_CR34","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1359\/jbmr.060707","volume":"21","author":"XH Luo","year":"2006","unstructured":"Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res. 2006;21(10):1648\u201356.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"606_CR35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.20036","volume":"200","author":"M Karst","year":"2004","unstructured":"Karst M, Gorny G, Galvin RJS, Oursler MJ. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-\u03b2 regulation of osteoclast differentiation. J Cell Physiol. 2004;200(1):99\u2013106.","journal-title":"J Cell Physiol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0606-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0606-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0606-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T22:19:00Z","timestamp":1715379540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0606-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0606-8","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]},"article-number":"606"}}